Actively Recruiting
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes
Led by Northwestern University · Updated on 2025-05-13
300
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
Sponsors
N
Northwestern University
Lead Sponsor
E
Endeavor Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this project is to use newly developed patient-reported outcomes to improve the clinical care of patients with benign prostatic hyperplasia. The use of new patient-centered tools will improve evaluation and clinical decision-making by including symptoms not commonly measured in men, such as urinary incontinence, and allow for more frequent assessment of lower urinary tract symptoms through remote surveillance. Through the use of care-coordination checklists, clinicians can be more responsive to post-treatment symptom changes, resulting in reduced bother from lower urinary tract symptoms and higher quality of life in patients with benign prostatic hyperplasia.
CONDITIONS
Official Title
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male sex
- Age 50 years or older
- Diagnosed by physician with BPH
- Able and willing to complete questionnaires
- Able and willing to provide informed consent
- Ability to read, write, and speak in English
- No plans to move from study area in next 6 months
You will not qualify if you...
- Female sex or intersex
- Younger than 50 years of age
- Being a prisoner or detainee
- Gross hematuria
- Interstitial cystitis
- Pelvic or endoscopic genitourinary surgery within the preceding 6 months (not including diagnostic cystoscopy)
- History of cystitis caused by tuberculosis, radiation therapy, or Cytoxan/cyclophosphamide therapy
- Ongoing symptomatic urethral stricture
- Current chemotherapy or other cancer therapy
- History of lower urinary tract or pelvic malignancy
- Severe neurological of psychiatric disorder that would prevent study participation (e.g., bipolar disorder, psychotic disorder, Alzheimer's Disease)
- Current moderate or severe substance use disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NorthShore University HealthSystem Research Institute
Glenview, Illinois, United States, 60026
Actively Recruiting
Research Team
D
Dacey Maglaque
CONTACT
P
Pooja Talaty
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here